Dr. Jack Elands has been the CEO of Amakem since its inception. Before, Jack was CBO of Silicos, an informatics based biotechnology company, CEO of Vitec, a specialty biotech company focused on antimicrobial products and VP of Business Development at Sidec, a biotech focused on developing protein based drugs. Jack started his pharmaceutical career at Marion Merrell Dow (Sanofi). He has published extensively and contributed to several patents. He received his undergraduate in medical biology from University of Utrecht in 1985. Jack was awarded his doctorate in Neuropharmacology from the Rudolf Magnus Institute at University of Utrecht in 1989.